•
Dec 31, 2023

ImmunityBio Q4 2023 Earnings Report

Total Revenue
$139K
Previous year: $73K
+90.4%
EPS
-$0.38
Previous year: -$0.27
+40.7%
Gross Profit
-$4.43M
Previous year: -$6.81M
-35.0%
Cash and Equivalents
$266M
Previous year: $105M
+154.6%
Free Cash Flow
-$123M
Previous year: -$110M
+12.4%
Total Assets
$504M
Previous year: $362M
+39.2%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment